Coca-Cola's stock is suffering its worst day in 17 months as concerns over consumer spending grows
Shares of Coca-Cola Co. (KO) were suffering their worst day in 17 months Thursday, amid a broad selloff in their consumer-staples peers and the broader stock market, amid growing fears that high interest rates and a slowing job market will derail the U.S. economy. The beverage giant's stock slumped 4.1% in afternoon trading, enough to lead the Dow Jones Industrial Average's losers. That would be the biggest one-day decline since it dropped 7.0% on May 18, 2022. The stock was also headed for its lowest close since Dec. 1, 2021. The Consumer Staples Select Sector SPDR ETF (XLP) was down 1.5% toward a one-year low and the S&P 500 gave up 0.2%. Earlier Thursday, branded consumer foods company Conagra Brands Inc. (CAG), which is also a component of the consumer staples ETF, reported quarterly sales that fell short of expectations, amid an "industry-wide slowdown in consumption and recent consumer behavior shifts."
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-05-23 1355ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting